NCT06356298

Brief Summary

The goal of this clinical trial is to compare the airway management effects of flexible reinforced laryngeal mask and endotracheal tube in childhood adenotonsillectomy. Participants will be randomly allocated to two groups: endotracheal tube group (ETT) and flexible reinforced laryngeal mask group (FLMA). For those in ETT group: they will be intubated after induction of anesthesia .For those in FLMA group: they will be put in flexible reinforced laryngeal mask after induction of anesthesia . The investigators will compare FLMA with ETT to see if flexible reinforced laryngeal mask can be used safely and effectively in childhood adenotonsillectomy,and if there will be less severe adverse events in FLMA.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Aug 2023

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 4, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 10, 2024

Completed
Last Updated

April 24, 2024

Status Verified

April 1, 2024

Enrollment Period

5 months

First QC Date

April 4, 2024

Last Update Submit

April 20, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Peak airway pressure

    Maximum peak airway pressure during surgery

    intraoperative period,10 minutes-1 hours

  • Petco2

    Petco2 at the end of surgery

    intraoperative period,10 minutes-1 hour

  • Ventilation leakage or not

    Using volume ventilation, tidal volume set to 10 ml /kg, Ventilation leakage is defined as reaching more than 20% of the set tidal volume.

    intraoperative period,10 minutes-1 hour

Secondary Outcomes (8)

  • Mean arterial pressure (MAP)

    Intraoperative period, 30 minutes - 1.5 hours

  • Heart rate (HR)

    Intraoperative period, 30 min - 1.5 hours

  • Recovery time

    Postoperative 30 minutes

  • Extubation time

    Postoperative 30 minutes

  • Dosage of anesthetic

    Intraoperative period, 30 minutes - 1.5 hours

  • +3 more secondary outcomes

Study Arms (2)

FLMA group

EXPERIMENTAL

In the FLMA group, a FLMA was applied.

Other: Airway Management: Flexible Reinforced Laryngeal Mask Airway

ETT group

EXPERIMENTAL

In the ETT group, guided by a visual laryngoscope, a ETT was intubated.

Other: Airway Management: Endotracheal Tube

Interventions

In the FLMA group, a FLMA was applied according to the manufacturer's recommendations. After lubrication of the posterior surface with oxybuprocaine hydrochloride gel, the FLMA was inserted after propping the shoulders. Its cuff was fully deflated before insertion, and the pressure was adjusted to 40 cm H2O with a manometer after insertion.

FLMA group

In the ETT group, guided by a visual laryngoscope, a ETT was intubated after lubrication of the surface with oxybuprocaine hydrochloride gel: endotracheal tube size = (16+ age) /4. The cuff pressure of ETT was adjusted to 20 cm H2O with a handheld manometer after inflation.

ETT group

Eligibility Criteria

Age2 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • patients who choose to have adenotonsillectomy surgery
  • the American Society of Anesthesiologists (ASA) physical status ranked I-II
  • the oropharyngeal anatomy is normal
  • competent to provide informed consent

You may not qualify if:

  • upper respiratory tract infection one week before surgery
  • oropharyngeal anatomy is abnormal
  • high risk of reflux aspiration
  • liver or kidney failure
  • psychiatric disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maternal and Child Health Hospital of Hubei Province

Wuhan, Hubei, 430000, China

Location

Study Officials

  • Na Li, MD

    Maternal and Child Health Hospital of Hubei Province

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Deputy Chief Physician

Study Record Dates

First Submitted

April 4, 2024

First Posted

April 10, 2024

Study Start

August 1, 2023

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

April 24, 2024

Record last verified: 2024-04

Locations